Related Experiment Videos
[Long-term follow-up of the Hancock prostheses]
F Fernández Vázquez1, J Verdejo París, J L Cervantes Escárcega
1Instituto Nacional de Cardiología Ignacio Chávez, México, D.F.
Archivos Del Instituto De Cardiologia De Mexico
|March 1, 1991
Summary
This study followed Hancock bioprostheses for 12.8 years, finding a 48.18% dysfunction rate. Half of patients with prosthetic dysfunction required re-operation, highlighting long-term cardiac valve performance concerns.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Device Performance
Context:
- Hancock bioprostheses are commonly used for heart valve replacement.
- Long-term outcomes and durability of bioprosthetic valves are critical for patient management.
- Understanding failure modes is essential for improving future prosthetic designs.
Purpose:
- To evaluate the long-term clinical outcomes and dysfunction rates of Hancock bioprostheses.
- To assess the histopathological findings in explanted Hancock bioprostheses.
- To compare the performance of Hancock bioprostheses with data from the literature.
Summary:
- A 12.8-year follow-up of 128 Hancock bioprostheses revealed a cumulative dysfunction rate of 48.18%.
- The annual dysfunction rate was calculated at 3.34% +/- 1.3%.
- Histopathological analysis was performed on 17 explanted prostheses, and 50% of patients with dysfunction underwent re-operation.
Impact:
- Provides crucial data on the long-term durability of Hancock bioprostheses.
- Informs clinical decision-making regarding the choice between biological and mechanical prostheses.
- Contributes to the understanding of bioprosthetic valve degeneration mechanisms.